Food for Thought: The AMX0035 (Albrioza) Situation | CORT Message Board Posts


Corcept Therapeutics Inc

  CORT website

CORT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  4212 of 4290  at  10/1/2022 4:35:26 PM  by

bubbarayjr


 In response to msg 4211 by  BSR_Alan
view thread

Re: Food for Thought: The AMX0035 (Albrioza) Situation

Yes, just one of many facts that bodes well for tiny BCLI. A VERY STRONG BUY IMO. Fact 1-Statically Significant Clinical Improvement in Patients with EARLY /LESS SEVERE who received NurOwn VS placebo as measured by THE Gold Standard ALSFRS-R physical function assessment. 2-Very Strong correlation between ALSFRS-R Stabilization or Improvement and BioMarker Data. This is fits perfectly with NurOwns theorized Mechanism of action AND the FDA has always show keen interest in the MOA of new treatments. 3-Approval of AMLXs drug with less clinical data supporting clinical efficacy. 4-FDAs Dr Dunns statement after AMLX approval: This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure, said Dr Billy Dunn, director of the Office of Neuroscience in the FDAs Center for Drug Evaluation and Research, adding: The FDA remains committed to facilitating the development of additional ALS treatments. Hmmm ADDITIONAL ALS TREATMENTS..NurOwn?
5-VERY STRONG ADVOCACY


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4213 Re: Food for Thought: The AMX0035 (Albrioza) Situation bubbarayjr 0 10/2/2022 8:34:58 AM




Financial Market Data provided by
.
Loading...